Pharmacoeconomics: evaluating the evaluators
Br J Clin Pharmacol
.
1997 May;43(5):451-6.
doi: 10.1046/j.1365-2125.1997.00575.x.
Authors
A Haycox
1
,
T Walley
Affiliation
1
Department of Pharmacology and Therapeutics, University of Liverpool, UK.
PMID:
9159558
PMCID:
PMC2042774
DOI:
10.1046/j.1365-2125.1997.00575.x
No abstract available
MeSH terms
Cost-Benefit Analysis
Drug Costs
Economics, Pharmaceutical*
Research Design